NCT04767269

Brief Summary

Present work was to investigate the possible efficacy of 0.2% cuminum cyminum herbal preparation as an antiplaque and antigingivitis agent when compared with chlorhexidine.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Jan 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2019

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2021

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2021

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

February 9, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 23, 2021

Completed
Last Updated

February 24, 2021

Status Verified

February 1, 2021

Enrollment Period

2 years

First QC Date

February 9, 2021

Last Update Submit

February 22, 2021

Conditions

Keywords

Mouthwashchlorhexidinestain

Outcome Measures

Primary Outcomes (3)

  • PLAQUE INDEX

    PLAQUE INDEX: Turesky-Gilmore-Glickman Modification of Quigley Hein 1962

    changes from baseline to 8 days

  • Gingival Index

    Gingival Index: Loe H ans Silness 1963

    changes from baseline to 8 days

  • Bleeding on probing

    Bleeding on probing: Muhlemann HR and Son 1971

    changes from baseline to 8 days

Study Arms (2)

cuminum cyminum mouthwash

EXPERIMENTAL

cuminum cyminum mouthwash in chronic gingivitis patients

Drug: Cuminum Cyminum

herbal mouthwash

ACTIVE COMPARATOR

herbal mouthwash in chronic gingivitis patients

Drug: herbal Mouthwash

Interventions

Cuminum Cyminum mouthwash in chronic gingivitis patients

Also known as: Cuminum Cyminum mouthwash
cuminum cyminum mouthwash

herbal mouthwash in chronic gingivitis patients

Also known as: herbal mouthwash in chronic gingivitis patients
herbal mouthwash

Eligibility Criteria

Age23 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • volunteers with minimum 20 natural teeth without restoration.
  • cooperative
  • motivated and committed to participate in the trial period.

You may not qualify if:

  • Antibiotic or anti-inflammatory therapy in previous month.
  • Any known allergy/ hypersensitivity to any product used in trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Periodontology, M.M. College of Dental Sciences and Research.

Ambāla, Haryana, 133207, India

Location

Related Publications (3)

  • Southern EN, McCombs GB, Tolle SL, Marinak K. The comparative effects of 0.12% chlorhexidine and herbal oral rinse on dental plaque-induced gingivitis. J Dent Hyg. 2006 Winter;80(1):12. Epub 2006 Jan 1.

    PMID: 16451766BACKGROUND
  • Salgado AD, Maia JL, Pereira SL, de Lemos TL, Mota OM. Antiplaque and antigingivitis effects of a gel containing Punica granatum Linn extract: a double-blind clinical study in humans. J Appl Oral Sci. 2006 Jun;14(3):162-6. doi: 10.1590/s1678-77572006000300003.

    PMID: 19089066BACKGROUND
  • Bettaieb I, Bourgou S, Wannes WA, Hamrouni I, Limam F, Marzouk B. Essential oils, phenolics, and antioxidant activities of different parts of cumin (Cuminum cyminum L.). J Agric Food Chem. 2010 Oct 13;58(19):10410-8. doi: 10.1021/jf102248j.

    PMID: 20809647BACKGROUND

Study Officials

  • surinder sachdeva, M.D.S.

    PROFESSOR

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: 1. Group phase A 2. Group phase B 3. Group phase C
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 9, 2021

First Posted

February 23, 2021

Study Start

January 1, 2019

Primary Completion

January 15, 2021

Study Completion

January 31, 2021

Last Updated

February 24, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share

Locations